CDKN2A and neoplasm: To more deeply investigate the role of CDKN2A expression in tumour prognosis and its association with drug target genes like FGFR3, we performed qRT-PCR expression profiling and reanalysis of existing CDKN2A and FGFR3 RNA expression data of MIBC after RC.